[DPHARMA] QoQ Quarter Result on 30-Sep-2022 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
09-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- 0.23%
YoY- -3.62%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 167,516 200,475 151,960 177,074 181,742 185,941 145,444 9.90%
PBT 16,515 28,292 15,347 21,385 21,473 26,646 17,128 -2.40%
Tax -3,974 -5,659 1,814 -5,036 -5,162 -6,355 -1,412 99.71%
NP 12,541 22,633 17,161 16,349 16,311 20,291 15,716 -14.00%
-
NP to SH 12,541 22,633 17,161 16,349 16,311 20,291 15,716 -14.00%
-
Tax Rate 24.06% 20.00% -11.82% 23.55% 24.04% 23.85% 8.24% -
Total Cost 154,975 177,842 134,799 160,725 165,431 165,650 129,728 12.62%
-
Net Worth 670,448 666,567 657,045 647,522 634,375 621,987 621,564 5.19%
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div 4,788 - 17,140 - 4,734 - 16,951 -57.04%
Div Payout % 38.19% - 99.88% - 29.02% - 107.86% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth 670,448 666,567 657,045 647,522 634,375 621,987 621,564 5.19%
NOSH 961,942 952,239 952,239 952,239 952,239 941,765 941,765 1.42%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 7.49% 11.29% 11.29% 9.23% 8.97% 10.91% 10.81% -
ROE 1.87% 3.40% 2.61% 2.52% 2.57% 3.26% 2.53% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 17.49 21.05 15.96 18.60 19.19 20.03 15.44 8.69%
EPS 1.31 2.38 1.80 1.72 1.72 2.19 1.67 -14.98%
DPS 0.50 0.00 1.80 0.00 0.50 0.00 1.80 -57.52%
NAPS 0.70 0.70 0.69 0.68 0.67 0.67 0.66 4.01%
Adjusted Per Share Value based on latest NOSH - 952,239
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 17.40 20.83 15.79 18.39 18.88 19.32 15.11 9.89%
EPS 1.30 2.35 1.78 1.70 1.69 2.11 1.63 -14.03%
DPS 0.50 0.00 1.78 0.00 0.49 0.00 1.76 -56.88%
NAPS 0.6965 0.6924 0.6825 0.6726 0.659 0.6461 0.6457 5.19%
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 1.30 1.56 1.61 1.30 1.20 1.49 1.68 -
P/RPS 7.43 7.41 10.09 6.99 6.25 7.44 10.88 -22.50%
P/EPS 99.28 65.63 89.34 75.72 69.66 68.17 100.67 -0.92%
EY 1.01 1.52 1.12 1.32 1.44 1.47 0.99 1.34%
DY 0.38 0.00 1.12 0.00 0.42 0.00 1.07 -49.94%
P/NAPS 1.86 2.23 2.33 1.91 1.79 2.22 2.55 -19.01%
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 24/08/23 22/05/23 23/02/23 09/11/22 16/08/22 17/05/22 15/02/22 -
Price 1.19 1.44 1.65 1.39 1.34 1.51 1.60 -
P/RPS 6.80 6.84 10.34 7.47 6.98 7.54 10.36 -24.53%
P/EPS 90.88 60.59 91.56 80.96 77.78 69.08 95.88 -3.51%
EY 1.10 1.65 1.09 1.24 1.29 1.45 1.04 3.82%
DY 0.42 0.00 1.09 0.00 0.37 0.00 1.13 -48.39%
P/NAPS 1.70 2.06 2.39 2.04 2.00 2.25 2.42 -21.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment